Neuroendocrine tumors (NET) Publications

Publications 2026

  1. Kjæstad E, Thiis-Evensen E, Edwin B, Bakka AO, Lilleaas AH, Thorsen Y, Schultz JK (2026)
    Extended D3 Mesenterectomy in Small Bowel Cancer Treatment: Feasibility and Importance for Staging. First Results of a Prospective Clinical Trial
    World J Surg (in press)
    DOI 10.1002/wjs.70550, PubMed 42682155
  2. Kjæstad E, Thiis-Evensen E, Sveen A, Bakka AO, Schultz JK (2026)
    Small Bowel Cancer: Implications of Preoperative Work-Up on Surgical Strategy
    World J Surg (in press)
    DOI 10.1002/wjs.70547, PubMed 42693594

Publications 2025

  1. Folkestad OH, Sponheim J, Åvitsland TL, Mordal KS, Vethe NT, Thiis-Evensen E (2025)
    The relationship between dose, concentration and toxicity of everolimus in the treatment of neuroendocrine tumors: A prospective observational study
    J Neuroendocrinol, 38 (1), e70107
    DOI 10.1111/jne.70107, PubMed 41204799
  2. Knigge UP, Kjellman M, Grønbæk H, Thiis-Evensen E, Schalin-Jäntti C, Welin S, Sørbye H, Schneider MDP, Belusa R, Nordic NET Biomarker Group (2025)
    Association rule mining of clinical and biomarker data in neuroendocrine tumors: A prospective study on disease progression
    J Neuroendocrinol, 37 (10), e70069
    DOI 10.1111/jne.70069, PubMed 40812788

Publications 2024

  1. Jansson-Rehnberg AS, Drewes AM, Sponheim J, Borgfelt C, Münch A, Graf W, Simrén M, Lindberg G, Hellström PM (2024)
    Diarrhoea of unknown cause: medical treatment in a stepwise manner<b>Management of Idiopathic Diarrhoea Based on Experience of Step-Up Medical Treatment</b>
    Scand J Gastroenterol, 59 (5), 543-546
    DOI 10.1080/00365521.2024.2313061, PubMed 38343268
  2. Olbjørn C, Hagen M, Moen AEF, Havdal LB, Sommen SL, Berven LL, Thiis-Evensen E, Stiansen-Sonerud T, Selvakumar J, Wyller VBB (2024)
    Longitudinal Fecal Microbiota Profiles in A Cohort of Non-Hospitalized Adolescents and Young Adults with COVID-19: Associations with SARS-CoV-2 Status and Long-Term Fatigue
    Pathogens, 13 (11)
    DOI 10.3390/pathogens13110953, PubMed 39599506
  3. Papantoniou D, Fröss-Baron K, Garske-Román U, Sundin A, Thiis-Evensen E, Grönberg M, Welin S, Tiensuu Janson E (2024)
    Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
    J Neuroendocrinol, 37 (3), e13379
    DOI 10.1111/jne.13379, PubMed 38477040

Publications 2023

  1. Edfeldt K, Hellman P, Granberg D, Lagergren P, Thiis-Evensen E, Sundin A, Andersson C (2023)
    Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours
    J Neuroendocrinol, 35 (10), e13342
    DOI 10.1111/jne.13342, PubMed 37807573
  2. Nesti C, Bräutigam K, Benavent M, Bernal L, Boharoon H, Botling J, Bouroumeau A, Brcic I, Brunner M, Cadiot G, Camara M, Christ E, Clerici T, Clift AK, Clouston H, Cobianchi L, Ćwikła JB, Daskalakis K, Frilling A, Garcia-Carbonero R, Grozinsky-Glasberg S, Hernando J, Hervieu V, Hofland J, Holmager P, Inzani F, Jann H, Jimenez-Fonseca P, Kaçmaz E, Kaemmerer D et al. (2023)
    Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study
    Lancet Oncol, 24 (2), 187-194
    DOI 10.1016/S1470-2045(22)00750-1, PubMed 36640790
  3. Papantoniou D, Grönberg M, Thiis-Evensen E, Sorbye H, Landerholm K, Welin S, Tiensuu Janson E (2023)
    Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
    Endocr Relat Cancer, 30 (3)
    DOI 10.1530/ERC-22-0316, PubMed 36629395
  4. Thiis-Evensen E, Boyar Cetinkaya R (2023)
    Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021
    J Neuroendocrinol, 35 (4), e13264
    DOI 10.1111/jne.13264, PubMed 36988112

Publications 2022

  1. Eshmuminov D, Studer DJ, Lopez Lopez V, Schneider MA, Lerut J, Lo M, Sher L, Musholt TJ, Lozan O, Bouzakri N, Sposito C, Miceli R, Barat S, Morris D, Oehler H, Schreckenbach T, Husen P, Rosen CB, Gores GJ, Masui T, Cheung TT, Kim-Fuchs C, Perren A, Dutkowski P, Petrowsky H, Thiis-Evensen E, Line PD, Grat M, Partelli S, Falconi M et al. (2022)
    Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal
    Ann Surg, 277 (5), e1063-e1071
    DOI 10.1097/SLA.0000000000005663, PubMed 35975918
  2. Knudsen MD, Kvaerner AS, Botteri E, Holme Ø, Hjartåker A, Song M, Thiis-Evensen E, Randel KR, Hoff G, Berstad P (2022)
    Lifestyle predictors for inconsistent participation to fecal based colorectal cancer screening
    BMC Cancer, 22 (1), 172
    DOI 10.1186/s12885-022-09287-9, PubMed 35168592
  3. Thiis-Evensen E (2022)
    Letter to the Editor: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
    World J Surg, 47 (4), 1083
    DOI 10.1007/s00268-022-06873-7, PubMed 36566298
  4. Thiis-Evensen E, Kjellman M, Knigge U, Gronbaek H, Schalin-Jäntti C, Welin S, Sorbye H, Del Pilar Schneider M, Belusa R, Nordic NET Biomarker Group (2022)
    Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors
    J Neuroendocrinol, 34 (7), e13176
    DOI 10.1111/jne.13176, PubMed 35829662

Publications 2021

  1. Janson ET, Knigge U, Dam G, Federspiel B, Grønbaek H, Stålberg P, Langer SW, Kjaer A, Arola J, Schalin-Jäntti C, Sundin A, Welin S, Thiis-Evensen E, Sorbye H (2021)
    Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
    Acta Oncol, 60 (7), 931-941
    DOI 10.1080/0284186X.2021.1921262, PubMed 33999752

Publications 2020

  1. Kjellman M, Knigge U, Welin S, Thiis-Evensen E, Gronbaek H, Schalin-Jäntti C, Sorbye H, Joergensen MT, Johanson V, Metso S, Waldum H, Søreide JA, Ebeling T, Lindberg F, Landerholm K, Wallin G, Salem F, Schneider MDP, Belusa R (2020)
    A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors
    Neuroendocrinology, 111 (9), 840-849
    DOI 10.1159/000510483, PubMed 32721955
  2. Knudsen MD, Botteri E, Holme Ø, Hjartåker A, Song M, Thiis-Evensen E, Norvard ER, Schult AL, Randel KR, Hoff G, Berstad P (2020)
    Association between lifestyle and site-specific advanced colorectal lesions in screening with faecal immunochemical test and sigmoidoscopy
    Dig Liver Dis, 53 (3), 353-359
    DOI 10.1016/j.dld.2020.11.021, PubMed 33309513
  3. Sorbye H, Meyer LS, Mordal KE, Myhre S, Thiis-Evensen E (2020)
    Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours
    Health Qual Life Outcomes, 18 (1), 188
    DOI 10.1186/s12955-020-01452-7, PubMed 32546236
  4. Thiis-Evensen E, Poole AC, Nguyen HT, Sponheim J (2020)
    Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease
    BMC Cancer, 20 (1), 466
    DOI 10.1186/s12885-020-06963-6, PubMed 32448245

Publications 2019

  1. Dam G, Grønbæk H, Sorbye H, Thiis Evensen E, Paulsson B, Sundin A, Jensen C, Ebbesen D, Knigge U, Tiensuu Janson E (2019)
    Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors
    Neuroendocrinology, 110 (3-4), 217-224
    DOI 10.1159/000503833, PubMed 31578011
  2. Fazio N, Martini JF, Croitoru AE, Schenker M, Li S, Rosbrook B, Fernandez K, Tomasek J, Thiis-Evensen E, Kulke M, Raymond E (2019)
    Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumors
    Future Oncol, 15 (17), 1997-2007
    DOI 10.2217/fon-2018-0934, PubMed 31084373
  3. Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Jahnsen J, Ricanek P, Vatn S, Moen AEF, Tannæs TM, Lindstrøm JC, Söderholm JD, Halfvarson J, Gomollón F, Casén C, Karlsson MK, Kalla R, Adams AT, Satsangi J, Perminow G (2019)
    Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome
    Clin Exp Gastroenterol, 12, 37-49
    DOI 10.2147/CEG.S186235, PubMed 30774408
  4. Vyakaranam AR, Crona J, Norlén O, Granberg D, Garske-Román U, Sandström M, Fröss-Baron K, Thiis-Evensen E, Hellman P, Sundin A (2019)
    Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE
    Cancers (Basel), 11 (7)
    DOI 10.3390/cancers11070909, PubMed 31261748

Publications 2018

  1. Løitegård T, Berntzen DT, Thiis-Evensen E (2018)
    The RECIST criteria compared to conventional response evaluation after peptide receptor radionuclide therapy in patients with neuroendocrine neoplasms
    Ann Nucl Med, 33 (3), 147-152
    DOI 10.1007/s12149-018-1316-2, PubMed 30406360
  2. Raymond E, Kulke MH, Qin S, Yu X, Schenker M, Cubillo A, Lou W, Tomasek J, Thiis-Evensen E, Xu JM, Croitoru AE, Khasraw M, Sedlackova E, Borbath I, Ruff P, Oberstein PE, Ito T, Jia L, Hammel P, Shen L, Shrikhande SV, Shen Y, Sufliarsky J, Khan GN, Morizane C, Galdy S, Khosravan R, Fernandez KC, Rosbrook B, Fazio N (2018)
    Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
    Neuroendocrinology, 107 (3), 237-245
    DOI 10.1159/000491999, PubMed 29991024

Publications 2017

  1. Boyar Cetinkaya R, Aagnes B, Myklebust TÅ, Thiis-Evensen E (2017)
    Survival in neuroendocrine neoplasms; A report from a large Norwegian population-based study
    Int J Cancer, 142 (6), 1139-1147
    DOI 10.1002/ijc.31137, PubMed 29082524
  2. Server A, Bargalló N, Fløisand Y, Sponheim J, Graus F, Hald JK (2017)
    Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation
    Neuroradiology, 59 (2), 105-126
    DOI 10.1007/s00234-017-1804-4, PubMed 28255902

Publications 2016

  1. Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Perminow G (2016)
    Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy
    Scand J Gastroenterol, 52 (4), 414-419
    DOI 10.1080/00365521.2016.1259653, PubMed 27887202

Publications 2015

  1. Boyar Cetinkaya R, Aagnes B, Thiis-Evensen E, Tretli S, Bergestuen DS, Hansen S (2015)
    Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010
    Neuroendocrinology, 104 (1), 1-10
    DOI 10.1159/000442207, PubMed 26562558
  2. Schrumpf E, Tan C, Karlsen TH, Sponheim J, Björkström NK, Sundnes O, Alfsnes K, Kaser A, Jefferson DM, Ueno Y, Eide TJ, Haraldsen G, Zeissig S, Exley MA, Blumberg RS, Melum E (2015)
    The biliary epithelium presents antigens to and activates natural killer T cells
    Hepatology, 62 (4), 1249-59
    DOI 10.1002/hep.27840, PubMed 25855031
  3. Sundnes O, Pietka W, Loos T, Sponheim J, Rankin AL, Pflanz S, Bertelsen V, Sitek JC, Hol J, Haraldsen G, Khnykin D (2015)
    Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences
    J Invest Dermatol, 135 (7), 1771-1780
    DOI 10.1038/jid.2015.85, PubMed 25739051
  4. Zahid W, Bergestuen D, Haugaa KH, Ueland T, Thiis-Evensen E, Aukrust P, Fosse E, Edvardsen T (2015)
    Myocardial Function by Two-Dimensional Speckle Tracking Echocardiography and Activin A May Predict Mortality in Patients with Carcinoid Intestinal Disease
    Cardiology, 132 (2), 81-90
    DOI 10.1159/000431076, PubMed 26111973

Publications 2014

  1. Boyar Cetinkaya R, Vatn M, Aabakken L, Bergestuen DS, Thiis-Evensen E (2014)
    Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors
    Scand J Gastroenterol, 49 (6), 734-41
    DOI 10.3109/00365521.2014.903432, PubMed 24679166
  2. Eskeland SL, Dalén E, Sponheim J, Lind E, Brunborg C, de Lange T (2014)
    European panel on the appropriateness of gastrointestinal endoscopy II guidelines help in selecting and prioritizing patients referred to colonoscopy--a quality control study
    Scand J Gastroenterol, 49 (4), 492-500
    DOI 10.3109/00365521.2014.886715, PubMed 24597781
  3. Janson ET, Sorbye H, Welin S, Federspiel B, Grønbæk H, Hellman P, Ladekarl M, Langer SW, Mortensen J, Schalin-Jäntti C, Sundin A, Sundlöv A, Thiis-Evensen E, Knigge U (2014)
    Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
    Acta Oncol, 53 (10), 1284-97
    DOI 10.3109/0284186X.2014.941999, PubMed 25140861
  4. Olbjørn C, Nakstad B, Småstuen MC, Thiis-Evensen E, Vatn MH, Perminow G (2014)
    Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients
    Scand J Gastroenterol, 49 (12), 1425-31
    DOI 10.3109/00365521.2014.966316, PubMed 25310799
  5. Vedeld HM, Andresen K, Eilertsen IA, Nesbakken A, Seruca R, Gladhaug IP, Thiis-Evensen E, Rognum TO, Boberg KM, Lind GE (2014)
    The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
    Int J Cancer, 136 (4), 844-53
    DOI 10.1002/ijc.29039, PubMed 24948044

Publications 2013

  1. Gedde-Dahl M, Thiis-Evensen E, Tjølsen AM, Mordal KS, Vatn M, Bergestuen DS (2013)
    Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors
    Endocr Connect, 2 (1), 50-4
    DOI 10.1530/EC-12-0077, PubMed 23781318
  2. Thiis-Evensen E, Kalager M, Bretthauer M, Hoff G (2013)
    Long-term effectiveness of endoscopic screening on incidence and mortality of colorectal cancer: A randomized trial
    United European Gastroenterol J, 1 (3), 162-8
    DOI 10.1177/2050640613483290, PubMed 24917955

Publications 2012

  1. Ahmed D, Danielsen SA, Aagesen TH, Bretthauer M, Thiis-Evensen E, Hoff G, Rognum TO, Nesbakken A, Lothe RA, Lind GE (2012)
    A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors
    Clin Transl Gastroenterol, 3 (12), e27
    DOI 10.1038/ctg.2012.21, PubMed 23324654
  2. Berstad P, Thiis-Evensen E, Vatn MH, Almendingen K (2012)
    Fatty acids in habitual diet, plasma phospholipids, and tumour and normal colonic biopsies in young colorectal cancer patients
    J Oncol, 2012, 254801
    DOI 10.1155/2012/254801, PubMed 23319946
  3. Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
    Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
    Arterioscler Thromb Vasc Biol, 33 (2), e47-55
    DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017
  4. Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, Dueland S, Hofsli E, Guren MG, Ohrling K, Birkemeyer E, Thiis-Evensen E, Biagini M, Gronbaek H, Soveri LM, Olsen IH, Federspiel B, Assmus J, Janson ET, Knigge U (2012)
    Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study
    Ann Oncol, 24 (1), 152-60
    DOI 10.1093/annonc/mds276, PubMed 22967994
  5. Sundlisaeter E, Edelmann RJ, Hol J, Sponheim J, Küchler AM, Weiss M, Udalova IA, Midwood KS, Kasprzycka M, Haraldsen G (2012)
    The alarmin IL-33 is a notch target in quiescent endothelial cells
    Am J Pathol, 181 (3), 1099-111
    DOI 10.1016/j.ajpath.2012.06.003, PubMed 22809957

Publications 2011

  1. Danielsen SA, Cekaite L, Ågesen TH, Sveen A, Nesbakken A, Thiis-Evensen E, Skotheim RI, Lind GE, Lothe RA (2011)
    Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome
    PLoS One, 6 (9), e24419
    DOI 10.1371/journal.pone.0024419, PubMed 21909432
  2. Haugaa KH, Bergestuen DS, Sahakyan LG, Skulstad H, Aakhus S, Thiis-Evensen E, Edvardsen T (2011)
    Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease
    J Am Soc Echocardiogr, 24 (6), 644-50
    DOI 10.1016/j.echo.2011.02.009, PubMed 21440415
  3. Lind GE, Danielsen SA, Ahlquist T, Merok MA, Andresen K, Skotheim RI, Hektoen M, Rognum TO, Meling GI, Hoff G, Bretthauer M, Thiis-Evensen E, Nesbakken A, Lothe RA (2011)
    Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
    Mol Cancer, 10, 85
    DOI 10.1186/1476-4598-10-85, PubMed 21777459
  4. Lind GE, Raiborg C, Danielsen SA, Rognum TO, Thiis-Evensen E, Hoff G, Nesbakken A, Stenmark H, Lothe RA (2011)
    SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis
    Oncogene, 30 (37), 3967-78
    DOI 10.1038/onc.2011.109, PubMed 21499309
  5. Ricanek P, Brackmann S, Perminow G, Lyckander LG, Sponheim J, Holme O, Høie O, Rydning A, Vatn MH, IBSEN II Study Group (2011)
    Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers
    Scand J Gastroenterol, 46 (9), 1081-91
    DOI 10.3109/00365521.2011.584897, PubMed 21619483
  6. Ågesen TH, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, Lind GE, Nesland JM, Bakka A, Mala T, Hauss HJ, Fetveit T, Vatn MH, Hovig E, Nesbakken A, Lothe RA, Skotheim RI (2011)
    CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
    Genes Immun, 12 (8), 653-62
    DOI 10.1038/gene.2011.43, PubMed 21716316

Publications 2010

  1. Berg M, Agesen TH, Thiis-Evensen E, INFAC-study group, Merok MA, Teixeira MR, Vatn MH, Nesbakken A, Skotheim RI, Lothe RA (2010)
    Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci
    Mol Cancer, 9, 100
    DOI 10.1186/1476-4598-9-100, PubMed 20459617
  2. Berg M, Danielsen SA, Ahlquist T, Merok MA, Ågesen TH, Vatn MH, Mala T, Sjo OH, Bakka A, Moberg I, Fetveit T, Mathisen Ø, Husby A, Sandvik O, Nesbakken A, Thiis-Evensen E, Lothe RA (2010)
    DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset
    PLoS One, 5 (11), e13978
    DOI 10.1371/journal.pone.0013978, PubMed 21103049
  3. Bergestuen DS, Edvardsen T, Aakhus S, Ueland T, Oie E, Vatn M, Aukrust P, Thiis-Evensen E (2010)
    Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis
    Neuroendocrinology, 92 (3), 168-77
    DOI 10.1159/000318014, PubMed 20720391
  4. Bergestuen DS, Gravning J, Haugaa KH, Sahakyan LG, Aakhus S, Thiis-Evensen E, Øie E, Aukrust P, Attramadal H, Edvardsen T (2010)
    Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors
    BMC Cancer, 10, 6
    DOI 10.1186/1471-2407-10-6, PubMed 20053285
  5. Janson ET, Sørbye H, Welin S, Federspiel B, Grønbaek H, Hellman P, Mathisen O, Mortensen J, Sundin A, Thiis-Evensen E, Välimäki MJ, Oberg K, Knigge U (2010)
    Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
    Acta Oncol, 49 (6), 740-56
    DOI 10.3109/0284186X.2010.492791, PubMed 20553100
  6. Sponheim J, Pollheimer J, Olsen T, Balogh J, Hammarström C, Loos T, Kasprzycka M, Sørensen DR, Nilsen HR, Küchler AM, Vatn MH, Haraldsen G (2010)
    Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts
    Am J Pathol, 177 (6), 2804-15
    DOI 10.2353/ajpath.2010.100378, PubMed 21037074

Publications 2009

  1. Bergestuen DS, Aabakken L, Holm K, Vatn M, Thiis-Evensen E (2009)
    Small intestinal neuroendocrine tumors: prognostic factors and survival
    Scand J Gastroenterol, 44 (9), 1084-91
    DOI 10.1080/00365520903082432, PubMed 19572232
  2. Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Küchler AM (2009)
    Interleukin-33 - cytokine of dual function or novel alarmin?
    Trends Immunol, 30 (5), 227-33
    DOI 10.1016/j.it.2009.03.003, PubMed 19359217
  3. Holme O, Thiis-Evensen E, Vatn MH (2009)
    Treatment of fulminant ulcerative colitis with cyclosporine A
    Scand J Gastroenterol, 44 (11), 1310-4
    DOI 10.3109/00365520903222673, PubMed 19891581

Publications 2008

  1. Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA (2008)
    Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
    Mol Cancer, 7, 94
    DOI 10.1186/1476-4598-7-94, PubMed 19117505
  2. Küchler AM, Pollheimer J, Balogh J, Sponheim J, Manley L, Sorensen DR, De Angelis PM, Scott H, Haraldsen G (2008)
    Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation
    Am J Pathol, 173 (4), 1229-42
    DOI 10.2353/ajpath.2008.080014, PubMed 18787100
  3. Lind GE, Ahlquist T, Kolberg M, Berg M, Eknaes M, Alonso MA, Kallioniemi A, Meling GI, Skotheim RI, Rognum TO, Thiis-Evensen E, Lothe RA (2008)
    Hypermethylated MAL gene - a silent marker of early colon tumorigenesis
    J Transl Med, 6, 13
    DOI 10.1186/1479-5876-6-13, PubMed 18346269

Publications 2006

  1. Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, Lothe RA (2006)
    ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis
    Cell Oncol, 28 (5-6), 259-72
    DOI 10.1155/2006/949506, PubMed 17167179
  2. Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, Lothe RA (2006)
    ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis
    Cell. Oncol., 28 (5-6), 259-272
  3. Thiis-Evensen E, Seip B, Vatn MH, Hoff GS (2006)
    Impact of a colonoscopic screening examination for colorectal cancer on later utilization of distal GI endoscopies
    Gastrointest Endosc, 64 (6), 948-54
    DOI 10.1016/j.gie.2006.08.006, PubMed 17140903

Publications 2005

  1. Bretthauer M, Lynge AB, Thiis-Evensen E, Hoff G, Fausa O, Aabakken L (2005)
    Carbon dioxide insufflation in colonoscopy: safe and effective in sedated patients
    Endoscopy, 37 (8), 706-9
    DOI 10.1055/s-2005-870154, PubMed 16032487

Publications 2004

  1. Hoff G, Grotmol T, Thiis-Evensen E, Bretthauer M, Gondal G, Vatn MH (2004)
    Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT)
    Gut, 53 (9), 1329-33
    DOI 10.1136/gut.2004.039032, PubMed 15306594

Publications 2003

  1. Bretthauer M, Hoff GS, Thiis-Evensen E, Huppertz-Hauss G, Skovlund E (2003)
    Air and carbon dioxide volumes insufflated during colonoscopy
    Gastrointest Endosc, 58 (2), 203-6
    DOI 10.1067/mge.2003.340, PubMed 12872086
  2. Bretthauer M, Skovlund E, Grotmol T, Thiis-Evensen E, Gondal G, Huppertz-Hauss G, Efskind P, Hofstad B, Thorp Holmsen S, Eide TJ, Hoff G (2003)
    Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy screening for colorectal cancer
    Scand J Gastroenterol, 38 (12), 1268-74
    DOI 10.1080/00365520310006513, PubMed 14750648

Publications 2002

  1. Bretthauer M, Hoff G, Thiis-Evensen E, Grotmol T, Holmsen ST, Moritz V, Skovlund E (2002)
    Carbon dioxide insufflation reduces discomfort due to flexible sigmoidoscopy in colorectal cancer screening
    Scand J Gastroenterol, 37 (9), 1103-7
    DOI 10.1080/003655202320378329, PubMed 12374237
  2. Bretthauer M, Hoff G, Thiis-Evensen E, Grotmol T, Larsen IK, Kjellevold Ø, Skovlund E (2002)
    Use of a disposable sheath system for flexible sigmoidoscopy in decentralized colorectal cancer screening
    Endoscopy, 34 (10), 814-8
    DOI 10.1055/s-2002-34273, PubMed 12244504
  3. Bretthauer M, Thiis-Evensen E, Huppertz-Hauss G, Gisselsson L, Grotmol T, Skovlund E, Hoff G (2002)
    NORCCAP (Norwegian colorectal cancer prevention): a randomised trial to assess the safety and efficacy of carbon dioxide versus air insufflation in colonoscopy
    Gut, 50 (5), 604-7
    DOI 10.1136/gut.50.5.604, PubMed 11950803
  4. Hoff G, Thiis-Evensen E, Vatn M (2002)
    Screening for sporadic colorectal cancer
    Endoscopy, 34 (6), 508; author reply 509-10
    DOI 10.1055/s-2002-31993, PubMed 12048642

Publications 2001

  1. Hoff G, Thiis-Evensen E, Grotmol T, Sauar J, Vatn MH, Moen IE (2001)
    Do undesirable effects of screening affect all-cause mortality in flexible sigmoidoscopy programmes? Experience from the Telemark Polyp Study 1983-1996
    Eur J Cancer Prev, 10 (2), 131-7
    DOI 10.1097/00008469-200104000-00003, PubMed 11330453
  2. Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH (2001)
    The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13-year follow-up
    Am J Gastroenterol, 96 (6), 1901-7
    DOI 10.1111/j.1572-0241.2001.03891.x, PubMed 11419846

Publications 2000

  1. Thiis-Evensen E, Hoff GS, Sauar J, Vatn MH (2000)
    Patient tolerance of colonoscopy without sedation during screening examination for colorectal polyps
    Gastrointest Endosc, 52 (5), 606-10
    DOI 10.1067/mge.2000.109804, PubMed 11060183

Publications 1999

  1. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH (1999)
    Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I
    Scand J Gastroenterol, 34 (4), 414-20
    DOI 10.1080/003655299750026443, PubMed 10365903
  2. Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH (1999)
    Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years
    Gut, 45 (6), 834-9
    DOI 10.1136/gut.45.6.834, PubMed 10562581
  3. Thiis-Evensen E, Wilhelmsen I, Hoff GS, Blomhoff S, Sauar J (1999)
    The psychologic effect of attending a screening program for colorectal polyps
    Scand J Gastroenterol, 34 (1), 103-9
    DOI 10.1080/00365529950172916, PubMed 10048741

Publications 1997

  1. Hoff G, Olafsson S, Thiis-Evensen E, Paulsen O, Johannesen O, Olafsson T, Hundevadt S, Sauar J (1997)
    [Integration of preventive medicine in an emergency department. A pedagogic model for improvement of communication]
    Tidsskr Nor Laegeforen, 117 (13), 1918-21
    PubMed 9214014
  2. Thiis-Evensen E, Hoff G, Johannesen O (1997)
    [Long-term result of a life style intervention group program]
    Tidsskr Nor Laegeforen, 117 (13), 1913-6
    PubMed 9214013

Publications 1996

  1. Hoff G, Sauar J, Vatn MH, Larsen S, Langmark F, Moen IE, Foerster A, Thiis-Evensen E (1996)
    Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study
    Scand J Gastroenterol, 31 (10), 1006-10
    DOI 10.3109/00365529609003121, PubMed 8898422

 
Scroll to top